Author

T. Jearanaiwitayakul

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Microbiology· 2

Signature Assays, Organisms & Methods

Click to filter · or open tag

Approach:experimental assay· 2 Organism:human· 2 Research Focus:drug response / drug discovery· 1 Research Focus:host-pathogen & immune response· 1 Organism:non-human primate· 1 Assay:whole-genome sequencing· 1

Frequent Co-Authors

A. D. Davidson· 2 shared D. A. Matthews· 2 shared J. Bazire· 2 shared M. Erdmann· 2 shared A. Darby· 1 shared B. Jones· 1 shared C. Hartley· 1 shared F. J. Salguero· 1 shared

Activity by Year

2021-2022 · peak 1/yr

Co-Author Collaboration Network

10 top collaborators · 45 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

2 shared papersMicrobiology

A. D. Davidson

Mutual co-authors in cluster

Author profile →

2 papers

Recent·Most cited

MicrobiologybioRxivOct 11, 2022

Development of SARS-CoV-2 replicons for the ancestral virus and variant of concern Delta for antiviral screening.

M. Erdmann, M. Kavanagh Williamson, T. Jearanaiwitayakul…·A. D. Davidson

The paper develops SARS-CoV-2 replicons for the ancestral virus and Delta variant to screen antiviral compounds, showing sensitivity to remdesivir.

DOI 10.3390/v17050597

humanexperimental assay

𝕏 PostBluesky

MicrobiologybioRxivPreprintDec 23, 2021

Rapid selection of P323L in the SARS-CoV-2 polymerase (NSP12) in humans and non-human primate models and confers a large plaque phenotype

X. Dong, H. Goldswain, R. Penrice-Randal…·J. A. Hiscox

The paper tracks the rapid emergence of the P323L mutation in SARS-CoV-2 polymerase in human and non-human primate models, showing it confers a larger plaque phenotype compared to P323.

DOI 10.1101/2021.12.23.474030

humannon-human primate

𝕏 PostBluesky